HOBBIT-META: HOBBIT 3: Mental Exercises and Temporal Alteration

Sponsor
University Hospital, Ghent (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06100068
Collaborator
(none)
40
1
2
10
4

Study Details

Study Description

Brief Summary

In the HOBBIT-trial by Vakaet et al. A protocol was developed to increase breath-hold time using (voluntary) hyperventilation and oxygenation to achieve DIBH times around 3 minutes.

Multiple non-medical interventions are being investigated to prolong a L-DIBH that are feasible in clinical practice. One of these methods will be to alter the time perception of the subjects. It has been noted in multiple studies (both medical and not) that slowing a person's perception of time results in an increase in breath-hold time. This alteration in time perception can be achieved with the use of a slowed clock as well as the usage of mental or physical exercises to preoccupy the subjects.

Volunteers will then be randomised into either the standard arm or the intervention arm. The intervention arm will follow standard protocol regarding DIBH preparation, though during the L-DIBH they will be asked to perform a simple mental exercise on a tablet. After 2 sessions of 3 L-DIBHs each, there will be a cross-over to the other arm in order to ascertain comfort and preference with each technique.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mental Exercises and Temporal Alteration
N/A

Detailed Description

Adjuvant radiation therapy has a well-established role in the treatment of breast cancer complementing surgery and systemic treatment, improving survival and local control in both local and regional disease. The long-term follow-up, however, does show increased cardiac morbidity and mortality. The risk of heart disease is greatest in patients receiving a higher heart dosage i.e., left sided breast cancer and irradiation of the internal mammary lymph nodes and does not appear to have a threshold. Lowering heart dose can be achieved by improved planning methods as well as increasing the distance between the target volume and the heart. A deep inspiration breath-hold (DIBH) is often used to this end.

An unassisted DIBH is between 12 and 30 seconds; a simple breast irradiation averages 4 DIBHS for completion. More advanced radiotherapy plans (including lymph nodes) needs up to 20 DIBHs. This great amount is both physically and mentally exhausting.

A protocol was developed to increase breath-hold time using (voluntary) hyperventilation and oxygenation to achieve DIBH times around 3 minutes.

Multiple non-medical interventions are being investigated to prolong a L-DIBH that are feasible in clinical practice. One of these methods will be to alter the time perception of the subjects. It has been noted in multiple studies (both medical and not) that slowing a person's perception of time results in an increase in breath-hold time. This alteration in time perception can be achieved with the use of a slowed clock as well as the usage of mental or physical exercises to preoccupy the subjects.

Other important factors on the duration of breath holds are stress and anxiety, which may also be influenced by (relaxation) exercises (including Abdominal breathing).

The standard protocol for the first phase will be based on the results of the original HOBBIT trial.

40 Volunteers will be asked to perform 3 L-DIBHs each preceded by 3 minutes of hyperventilation at 16 breaths/min with 40L/min at FiO2 60%.

Volunteers will then be randomised into either the standard arm or the intervention arm. The intervention arm will follow standard protocol regarding DIBH preparation, though during the L-DIBH they will be asked to perform a simple mental exercise on a tablet.

Data regarding L-DIBH time, side-effects and volunteer reported stress and comfort will be reported.

Volunteers in each group will be asked to perform 2 series of 3 L-DIBHs on 2 separate days. After having finished these 2 series, there will be a cross-over to the other arm. This cross-over will evaluate the known effect of the learning bias that we see with breath-hold and show whether this effect has an impact on the anticipated benefit of the intervention. With the cross-over we can also ascertain volunteer comfort and preference with each the technique.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Hyperventilation and Oxygenation to Increase Breath Hold in Breast Cancer Irradiation Treatment (HOBBIT) 3: Mental Exercises and Temporal Alteration
Anticipated Study Start Date :
Nov 2, 2023
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard L-DIBH

Starts with 2 sessions of normal L-DIBH followed by 2 sessions of L-DIBH combined with mental exercises.

Behavioral: Mental Exercises and Temporal Alteration
Mental exercises during L-DIBH to distort the awareness of passage of time

Experimental: Intervention L-DIBH

Starts with 2 sessions of of L-DIBH combined with mental exercises followed by 2 sessions of normal L-DIBH.

Behavioral: Mental Exercises and Temporal Alteration
Mental exercises during L-DIBH to distort the awareness of passage of time

Outcome Measures

Primary Outcome Measures

  1. Difference in average L-DIBH time between standard and experimental L-DIBH [1 year]

    Difference in average L-DIBH time between standard and experimental L-DIBH

Secondary Outcome Measures

  1. Patient reported comfort [1 year]

    Comfort on a scale of 0 to 10 where 0 is not comfortable at all and 10 is very comfortable

  2. Patient preferece for standard or experimental L-DIBH setup [1 year]

    What setup do patients prefer

  3. Average L-DIBH time [1 year]

    average time of a L-DIBH (in standard and experimental setup)

  4. Median L-DIBH time [1 year]

    Median time of a L-DIBH (in standard and experimental setup)

  5. Minimum and Maximum L-DIBH time [1 year]

    Minimum and Maximum time of a L-DIBH (in standard and experimental setup)

  6. Oxygen Saturation [1 year]

    Oxygen Saturation during the L-DIBH

  7. Heart Rate [1 year]

    Heart Rate during the hyperventilation and during the L-DIBH

  8. Patient report Pain [1 year]

    Pain on a scale of 0 to 10 where 0 is no pain and 10 is the worst pain possible

  9. Correctness of the mental exercise [1 year]

    A grading (perfect-good-fair-poor) regarding the score achieved during the mental exercise

Other Outcome Measures

  1. Breath-Hold related side-effects [1 year]

    Various side-effects (regarding, nausea, dizziness, coughing, palpitations, cramps)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Volunteer

  • Karnofsky index of at least 90

  • Able to perform a single DIBH of at least twenty seconds without assistance

  • Age ≥ 18 years

  • Informed consent obtained, signed and dated before specific protocol procedures

  • Female

Exclusion Criteria:
  • Pregnant women

  • Volunteers above WHO Obesity class II (BMI>35kg/m²)

  • Subjects on oxygen treatment during day or night

  • COPD or Asthma patients

  • Volunteers with pulmonary hypertension

  • Gastric tube present

  • Smoking

  • Previous and substantial breath-holding experience in the past year (e.g., diver, etc.)

  • Mental condition rendering the volunteer unable to understand the nature, scope and possible consequences of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital - Radiotherapy Department Ghent Belgium 9000

Sponsors and Collaborators

  • University Hospital, Ghent

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT06100068
Other Study ID Numbers:
  • EC/2023/0256
First Posted:
Oct 25, 2023
Last Update Posted:
Oct 25, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 25, 2023